D8 (DEH) Competitors

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Competitors Insider Trades Social Media

DEH vs. HSCS, POAI, NTRB, LFWD, MLSS, TRIB, IMNN, BSGM, JAN, and CHEK

Should you be buying D8 stock or one of its competitors? The main competitors of D8 include Heart Test Laboratories (HSCS), Predictive Oncology (POAI), Nutriband (NTRB), ReWalk Robotics (LFWD), Milestone Scientific (MLSS), Trinity Biotech (TRIB), Imunon (IMNN), BioSig Technologies (BSGM), JanOne (JAN), and Check-Cap (CHEK). These companies are all part of the "medical" sector.

D8 vs.

Heart Test Laboratories (NASDAQ:HSCS) and D8 (NYSE:DEH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, community ranking, risk, analyst recommendations and valuation.

: In the previous week, Heart Test Laboratories had 1 more articles in the media than D8. MarketBeat recorded 1 mentions for Heart Test Laboratories and 0 mentions for D8. Heart Test Laboratories' average media sentiment score of -0.73 beat D8's score of -1.02 indicating that D8 is being referred to more favorably in the news media.
Company Overall Sentiment
Heart Test Laboratories Negative
D8 Negative
: 17.2% of Heart Test Laboratories shares are owned by institutional investors. Comparatively, 65.4% of D8 shares are owned by institutional investors. 2.7% of Heart Test Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: Heart Test Laboratories received 3 more outperform votes than D8 when rated by MarketBeat users.
Company Underperform Outperform
Heart Test Laboratories Outperform Votes
3
75.00%
Underperform Votes
1
25.00%
D8 N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Heart Test Laboratories N/A N/A -$6.35M -$0.48 -0.21
D8 N/A N/A -$9.46M N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heart Test Laboratories
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
D8
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Heart Test Laboratories' return on equity of 0.00% beat D8's return on equity.
Company Net Margins Return on Equity Return on Assets
Heart Test Laboratories N/A -381.92% -134.17%
D8 N/A N/A N/A

Company	Overall Sentiment
Heart Test Laboratories	Negative
D8	Negative

Company	Underperform	Outperform
Heart Test Laboratories	Outperform Votes 3 75.00%	Underperform Votes 1 25.00%
D8	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Test Laboratories	N/A	N/A	-$6.35M	-$0.48	-0.21
D8	N/A	N/A	-$9.46M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Test Laboratories	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
D8	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Net Margins	Return on Equity	Return on Assets
Heart Test Laboratories	N/A	-381.92%	-134.17%
D8	N/A	N/A	N/A

Summary

Heart Test Laboratories and D8 tied by winning 4 of the 8 factors compared between the two stocks.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Get D8 News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DEH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DEH vs. The Competition

Export to Excel

Metric	D8	Surgical Appliances & Supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$12.42M	$8.61B	$4.80B	$17.25B
Dividend Yield	N/A	1.41%	2.94%	3.62%
P/E Ratio	N/A	27.10	256.72	24.50
Price / Sales	N/A	59.54	2,480.00	11.82
Price / Cash	N/A	21.33	47.10	17.10
Price / Book	2.40	5.67	4.55	4.85
Net Income	-$9.46M	$174.92M	$104.14M	$970.56M

D8 Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSCS Heart Test Laboratories	0 of 5 stars	$0.11 flat	N/A	-90.1%	$7.39M	$18,600.00	-0.23	12
POAI Predictive Oncology	0 of 5 stars	$1.76 -7.9%	N/A	-80.0%	$7.15M	$1.78M	-0.51	31	Positive News Gap Up
NTRB Nutriband	0 of 5 stars	$4.27 -1.8%	N/A	+19.2%	$33.40M	$2.08M	-6.37	3	Upcoming Earnings Gap Up
LFWD ReWalk Robotics	2.6787 of 5 stars	$5.06 -3.6%	$21.00 +315.0%	N/A	$43.01M	$13.85M	-1.76	108	Analyst Revision News Coverage Gap Down
MLSS Milestone Scientific	0 of 5 stars	$0.59 -6.3%	N/A	-25.8%	$48.26M	$9.83M	-5.90	20	Analyst Report Gap Up
TRIB Trinity Biotech	0 of 5 stars	$1.93 flat	N/A	-58.1%	$14.71M	$71.39M	-0.61	398	Analyst Report Gap Down
IMNN Imunon	2.6941 of 5 stars	$1.55 +4.0%	$13.00 +738.7%	-3.8%	$14.57M	$500,000.00	-0.71	31	News Coverage Gap Down
BSGM BioSig Technologies	0 of 5 stars	$1.62 +30.6%	N/A	-87.8%	$14.55M	$290,000.00	-0.34	47	Gap Down High Trading Volume
JAN JanOne	0 of 5 stars	$2.98 +18.3%	N/A	+273.7%	$14.78M	$39.61M	0.00	199
CHEK Check-Cap	0 of 5 stars	$2.54 -1.9%	N/A	+67.4%	$14.86M	N/A	-0.84	85	Positive News

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NYSE:DEH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

D8 (DEH) Competitors

DEH vs. HSCS, POAI, NTRB, LFWD, MLSS, TRIB, IMNN, BSGM, JAN, and CHEK

D8 vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DEH vs. The Competition

D8 Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info